Clinical Trial Update: Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing conversion from tacrolimus to sirolimus in African American renal transplant recipients, with focus on graft function and chron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Nephropathy
• Renal Transplantation

Drugs mentioned

• Prograf (Tacrolimus)
• Rapamune (sirolimus)

Snippet

Sponsor: Temple University | Conditions: Glomerular Filtration Rate, Chronic Allograft Nephropathy | Phase 4 | Status: UNKNOWN